Abstract:Background Herpes simplex virus (HSV) is a common human pathogen that causes a variety of diseases, including oral-labial, genital lesions and life-threatening encephalitis. The antiviral nucleoside analogues such as acyclovir are currently used in anti-HSV therapies; however, clinical overuse of these drugs has led to the emergence of drug-resistant viral strains. Hence, there is an urgent need to develop new anti-HSV agents. Methods To identify novel anti-HSV-1 compounds, we screened the LOPAC small scale library of 1280 bioactive compounds to identify inhibitors of HSV-1-induced necroptosis. Further experiments including western blot analysis, Q-PCR analysis and immunohistochemistry were performed to explore the antiviral mechanism of the compounds. Results Here, we identified PHA767491 as a new inhibitor of HSV. PHA767491 potently blocked the proliferation of HSV in cells, as well as HSV induced cell death. Further, we found that PHA767491 strongly inhibited HSV infection post viral entry. Moreover, PHA767491 reduced the expression of viral genes required for DNA synthesis including UL30/42 DNA polymerase and UL5/8/52 helicase-primase complex. The essential immediate early (IE) genes such as ICP4 and ICP27 are critical for the expression of the early and late genes. Of note, PHA767491 inhibited the expression of all IE genes of both HSV-1 and HSV-2. Importantly, PHA767491 reduced viral titers in the tissues from the mice infected with HSV-1. Consistently, immunohistochemistry analysis showed that PHA767491 dramatically attenuated expression of viral protein gB in the livers. Conclusions Taken together, PHA767491 has potent anti-HSV activity by inhibiting viral replication both in vitro and in mouse model. Thus, PHA767491 could be a promising agent for the development of new anti-HSV therapy.

Antiherpetic activities of acidic protein bound polysacchride isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine

Possible Mode of Action of Antiherpetic Activities of a Proteoglycan Isolated from the Mycelia of Ganoderma Lucidum in Vitro.

Possible mechanism underlying the antiherpetic activity of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro.

Inhibition Effects and Mechanisms of Marine Polysaccharide PSSD against Herpes Simplex Virus Type 2

Anti-herpes Simplex Virus Activity of Polysaccharides from Eucheuma Gelatinae.

Combined Effect of Basic Antiherpetic Drugs with a New Inhibitor of the Terminase Complex of Herpes Simplex Virus Type 1 in Vero Cell Cultures

Preparation and antiherpetic activities of chemically modified polysaccharides from Polygonatum cyrtonema Hua

Anti-Herpesviral Property and Mode of Action of A Polysaccharide from Brown Seaweed (hydroclathrus Clathratus)

Anti-herpes simplex virus efficacies of 2-aminobenzamide derivatives as novel HSP90 inhibitors.

Antiviral activity of arbidol hydrochloride against herpes simplex virus I in vitro and in vivo

Preparation of a monoPEGylated derivative of cyanovirin-N and its virucidal effect on acyclovir-resistant strains of herpes simplex virus type 1

Antiviral Activity of PHA767491 Against Human Herpes Simplex Virus in Vitro and in Vivo

Antiviral Activities of Polysaccharides from Eucheuma Gelatinae and Eucheuma Striatum in Vitro

Inhibition of Herpes Simplex Virus Infection by a GLP Isolated from Mycelium of Ganoderma Lucidum

Study on the Antivirus Activity of Crude Polysaccharide Extracted from the Caudex of Undaria Pinnatifida in Vitro

Anti-HSV-1 Activity of Glycyrrhizic Acid Nanoparticles Prepared by Supercritical Antisolvent Process

A review: Natural polysaccharides from medicinal plants and microorganisms and their anti-herpetic mechanism

Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study

Polyphenolic-protein-polysaccharide conjugates from Spica of Prunella vulgaris: Chemical profile and anti-herpes simplex virus activities.

The antiherpetic and anti-inflammatory activity of the frog-derived peptide Hylin-a1

Quantitative Study on Synergistic Effect of Radix Astragalus A6 and Acyclovir Against Herpes Simplex Virus Type I by Polymerase Chain Reaction